Bio Green Med Solution, Inc. (BGMS)
NASDAQ: BGMS · Real-Time Price · USD
0.950
-0.010 (-1.05%)
Mar 6, 2026, 2:02 PM EST - Market open
Bio Green Med Solution Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Revenue | 0.08 | 0.04 | 0.42 | - | - | - | Upgrade
|
| Revenue Growth (YoY) | 9.46% | -89.76% | - | - | - | - | Upgrade
|
| Cost of Revenue | 1.74 | 6.56 | 18.72 | - | - | - | Upgrade
|
| Gross Profit | -1.66 | -6.52 | -18.3 | - | - | - | Upgrade
|
| Selling, General & Admin | 7.42 | 5.39 | 6.72 | 7.38 | 7.46 | 5.88 | Upgrade
|
| Research & Development | 0.1 | 0.09 | 0.43 | 20.27 | 14.93 | 4.76 | Upgrade
|
| Operating Expenses | 7.51 | 5.49 | 7.15 | 27.66 | 22.39 | 10.64 | Upgrade
|
| Operating Income | -9.17 | -12 | -25.45 | -27.66 | -22.39 | -10.64 | Upgrade
|
| Interest & Investment Income | 0.05 | 0.01 | 0.27 | 0.21 | 0.02 | 0.04 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.09 | -0.05 | -0.41 | 0.23 | 0.04 | 0.02 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.02 | 0.05 | 0.05 | 1.3 | 0.14 | 0.89 | Upgrade
|
| EBT Excluding Unusual Items | -9.19 | -11.99 | -25.55 | -25.92 | -22.19 | -9.68 | Upgrade
|
| Pretax Income | -4.24 | -11.99 | -25.55 | -25.92 | -22.19 | -9.68 | Upgrade
|
| Income Tax Expense | 1.2 | -0.78 | -3 | -4.72 | -3.73 | -1.24 | Upgrade
|
| Earnings From Continuing Operations | -5.44 | -11.21 | -22.56 | -21.2 | -18.46 | -8.45 | Upgrade
|
| Net Income | -5.44 | -11.21 | -22.56 | -21.2 | -18.46 | -8.45 | Upgrade
|
| Preferred Dividends & Other Adjustments | 1.54 | - | 0.2 | 0.2 | 0.2 | 3.98 | Upgrade
|
| Net Income to Common | -6.97 | -11.21 | -22.76 | -21.4 | -18.66 | -12.42 | Upgrade
|
| Shares Outstanding (Basic) | 1 | 0 | - | - | - | - | Upgrade
|
| Shares Outstanding (Diluted) | 1 | 0 | - | - | - | - | Upgrade
|
| EPS (Basic) | -6.73 | -502.46 | - | - | - | - | Upgrade
|
| EPS (Diluted) | -6.73 | -502.46 | - | - | - | - | Upgrade
|
| Free Cash Flow | -6.09 | -7.99 | -16.12 | -20.83 | -18.57 | -8.03 | Upgrade
|
| Free Cash Flow Per Share | -5.88 | -358.07 | - | - | - | - | Upgrade
|
| Operating Margin | -11324.69% | -27916.28% | -6060.24% | - | - | - | Upgrade
|
| Profit Margin | -8609.88% | -26074.42% | -5418.10% | - | - | - | Upgrade
|
| Free Cash Flow Margin | -7522.22% | -18581.40% | -3837.62% | - | - | - | Upgrade
|
| EBITDA | -9.17 | -12 | -25.42 | -27.62 | -22.35 | -10.62 | Upgrade
|
| D&A For EBITDA | 0 | 0.01 | 0.03 | 0.03 | 0.04 | 0.02 | Upgrade
|
| EBIT | -9.17 | -12 | -25.45 | -27.66 | -22.39 | -10.64 | Upgrade
|
| Revenue as Reported | 0.08 | 0.04 | 0.42 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.